Brief: Havencrest Healthcare Partners Reports Stake Of 12.04% In Oncology Institute As Of Dec 28, 2023
Jan 2 (Reuters) - Oncology Institute Inc TOI.O :
* HAVENCREST HEALTHCARE PARTNERS GP, LLC REPORTS STAKE OF
12.04%
IN ONCOLOGY INSTITUTE AS OF DEC 28, 2023 VERSUS. PREVIOUS STAKE
OF 18.9% AS OF NOV 3, 2022
Further company coverage: TOI.O
Recent news on Oncology Institute
See all newsOncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million
Oncology Institute beats Q4 revenue estimates, net loss narrows
Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Brief: The Oncology Institute Announces Leadership Promotions